WIGZELL HANS LENNART RUDOLF sold 26.6% of their position (5K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $584.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2020ACC: 0001209191-20-017097
Director
Since Nov 2018
-5K
Net shares
Net seller
$584.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$8.46
Trade value
$42.30K
% of position
36.3%
3/4/2020
13.79K→18.79K
Common Stock
Direct
Shares
−5K
Price / share
$116.89
Trade value
$584.45K
% of position
26.6%
3/4/2020
18.79K→13.79K
Total
Net shares
+0.00
Net value
-$542.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2020 | M · Option Exercise | +5K | $8.46 | $42.30K | 36.3% | 13.79K | 18.79K |
| Common Stock Direct | 3/4/2020 | S · Sale | −5K | $116.89 | $584.45K | 26.6% | 18.79K | 13.79K |
| Total | +0.00 | -$542.15K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
8.46
Held after
0.00
Exercisable
—
3/4/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock5K shares | 3/4/2020 | M · Option Exercise | −5K | 8.46 | — | 0.00 |